Status:
COMPLETED
PET Neuroimaging of [11C]Mirtazapine
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
The Danish Medical Research Council
Fund for Advancement of Medical Science
Conditions:
Mental Disorders
Mood Disorders
Eligibility:
All Genders
20-60 years
Phase:
PHASE4
Brief Summary
Recent studies show that 25 - 30% of depressed patients never fully recover, resulting in a treatment-resistant condition. Thus, depression is a major cause of human suffering. We are interested in fi...
Detailed Description
This project uses a double-blind, placebo-controlled, parallel-group design to determine whether there is a reliable relationship between the level of the antidepressant drug mirtazapine in the bloods...
Eligibility Criteria
Inclusion
- Healthy volunteer
- Drug-free
- No cognitive impairment
- Normal brain anatomy based on MRI
- Contraceptive use by females
Exclusion
- PET scanned during past year
- Chronic illness
- Daily use of drug
- Mental illness
- Abnormal value in routine blood analysis
- Pregnancy
- Breast feeding
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00288782
Start Date
February 1 2006
End Date
April 1 2007
Last Update
April 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Psychiatric Research, Psychiatric Hospital of Aarhus University
Risskov, Denmark, 8240